Presentation TVT 2020 SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes Presenter: Susheel K. Kodali June 21, 2020
Presentation TVT 2020 Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis Presenter: Tsuyoshi Kaneko June 21, 2020
Presentation TVT 2020 First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation Presenter: Hasan Jilaihawi June 21, 2020
Presentation TVT 2020 Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality Presenter: Tsuyoshi Kaneko June 20, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry Presenter: Guilherme F. Attizzani June 20, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis Presenter: Bruce Rutkin June 20, 2020
Presentation TVT 2020 Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States Presenter: Tamim Nazif June 20, 2020
Presentation TVT 2019 The LOTUS Edge TAVR System: Clinical Trial Updates Presenter: Chris Meduri June 13, 2019
Presentation TVT 2017 Will the Heart Team Survive the Modern Era of Minimalist TAVR? Presenter: Martin B. Leon, Hendrik Treede, Wilson Y. Szeto June 16, 2017
Presentation TVT 2017 A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability Presenter: Martin B. Leon, Hendrik Treede June 16, 2017
Presentation TVT 2017 Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials Presenter: Martin B. Leon, Hendrik Treede, Philippe Pibarot June 16, 2017
Presentation TVT 2017 The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy Presenter: Martin B. Leon, Hendrik Treede, George D. Dangas June 16, 2017
Presentation TVT 2017 An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps Presenter: Martin B. Leon, Hendrik Treede, Philipp Blanke June 16, 2017
Presentation TVT 2017 Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications Presenter: Martin B. Leon, Hendrik Treede, Raj Makkar June 16, 2017
Presentation TVT 2017 Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future? Presenter: David J. Cohen, Jeffrey J. Popma, Robert O. Bonow June 16, 2017
Presentation TVT 2017 Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux June 16, 2017
Presentation TVT 2017 Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem June 16, 2017
Presentation TVT 2017 A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis Presenter: David J. Cohen, Jeffrey J. Popma, Howard C. Herrmann June 16, 2017
Presentation TVT 2017 A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon June 16, 2017